Protein Summary
Involved in the regulation of innate immune response. Acts as negative regulator of Toll-like receptor and interferon-regulatory factor (IRF) signaling pathways. Contributes to the regulation of transcriptional activation of NF-kappa-B target genes in response to endogenous proinflammatory stimuli. May play a role during early embryonic development. Probably involved in pre-mRNA splicing.
- ENST00000221899
- ENSP00000221899
- ENSG00000105298
- ENST00000248420
- ENSP00000248420
- ENST00000429344
- ENSP00000415078
- ENST00000585942
- ENSP00000465751
- C19orf29
- fSAPc
- C19orf29
- NY-REN-24
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 0.91 | ||
histone modification site profile | 0.8 | ||
drug perturbation | 0.71 | ||
transcription factor perturbation | 0.68 | ||
transcription factor | 0.66 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 37.7 (req: < 5)
Gene RIFs: 5 (req: <= 3)
Antibodies: 77 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 37.7 (req: >= 5)
Gene RIFs: 5 (req: > 3)
Antibodies: 77 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 15
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0